Improving the outcome of tuberculous meningitis in childhood

Insights

Cerebrospinal fluid shunting significantly improves outcomes for children with tuberculous meningitis (TBM) and hydrocephalus. Relieving cerebrospinal fluid flow obstruction is crucial for reducing mortality and morbidity in these patients.

Area of Science:

  • Pediatrics
  • Neurology
  • Infectious Diseases

Background:

  • Tuberculous meningitis (TBM) is a severe infection affecting the central nervous system.
  • Hydrocephalus is a common complication of TBM, leading to increased intracranial pressure.
  • Untreated hydrocephalus in TBM is associated with high mortality and morbidity.

Purpose of the Study:

  • To evaluate the efficacy of cerebrospinal fluid (CSF) shunting in managing hydrocephalus secondary to TBM.
  • To compare treatment outcomes in TBM patients with hydrocephalus who underwent CSF shunting versus those who did not.

Main Methods:

  • A comparative study involving two matched groups of 28 children with TBM and hydrocephalus.
  • Both groups received standard antituberculosis therapy.
  • One group underwent ventriculoperitoneal or lumboperitoneal CSF shunting procedures.

Main Results:

  • Patients who received CSF shunting demonstrated superior treatment outcomes compared to the non-shunted group.
  • Shunting effectively relieved the obstruction to CSF flow.
  • This intervention was associated with reduced mortality and morbidity.

Conclusions:

  • Cerebrospinal fluid shunting is an effective adjunctive treatment for hydrocephalus in children with TBM.
  • Relieving CSF flow obstruction through shunting significantly improves patient prognosis.
  • Early surgical intervention should be considered for TBM-associated hydrocephalus.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...